# A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients

> **NCT04307511** · PHASE4 · UNKNOWN · sponsor: **Shanghai Tong Ren Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Acute Coronary Syndrome Patients With Diabetes After PCI

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT04307511
- **Lead sponsor:** Shanghai Tong Ren Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-20
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-05-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04307511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04307511, "A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04307511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*